Eosinophilic Esophagitis
📧 Sign up to get email alerts when something new happens for Eosinophilic Esophagitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Results: The Immune Directed Individualized Elimination Therapy (iDIET) Study [NA]
Completed clinical trial results for the iDIET study investigating eosinophilic esophagitis (EoE).
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE [Phase 3]
Phase 3 trial assessing once-daily versus twice-daily budesonide orodispersible tablets for induction of remission in eosinophilic esophagit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States [NA]
A clinical trial evaluating the Esophageal String Test as a diagnostic screening tool for eosinophilic esophagitis in people with dysphagia …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
A U.S. registry study of eosinophilic esophagitis patients treated with dupilumab (DUPIXENT) as standard of care is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis [Phase 3]
This document provides an update on a Phase 3 trial evaluating the efficacy and safety of Tezepelumab for eosinophilic esophagitis. The stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-04-20EMA Authorised: Dupixent (dupilumab) — Sanofi Winthrop Industrie
The EMA authorised Dupixent (dupilumab) for multiple EU indications, including atopic dermatitis, prurigo nodularis, eosinophilic esophagiti…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis [NA]
A clinical trial is investigating partial enteral nutrition with a dairy-free diet for eosinophilic esophagitis and is currently recruiting.
-
EMA approval · 2026-04-15EMA Authorised: Jorveza (Budesonide) — Dr. Falk Pharma GmbH
EMA authorised Jorveza (budesonide) by Dr. Falk Pharma GmbH for eosinophilic esophagitis; the approval is designated orphan medicine with ac…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis [Phase 3]
A Phase 3 trial evaluating dupilumab in young children with eosinophilic esophagitis is currently recruiting, sponsored by Regeneron.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis [Phase 3]
Phase 3 safety study results for CC-93538 in adult and adolescent participants with eosinophilic esophagitis; results were posted on 2026-04…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: PRospective Registry of Esophageal Motility
This item notes a prospective registry study on esophageal motility that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Natural History and Genetics of Food Allergy and Related Conditions
Ongoing NIAID study aims to characterize the natural history and genetics of food allergy and related conditions, including Loeys-Dietz synd…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Patient-Centered Decision Support for Eosinophilic Esophagitis [NA]
A University of Michigan-sponsored clinical trial is recruiting to study patient-centered decision support for eosinophilic esophagitis.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis [Phase 2]
This clinical trial update indicates that NSI-8226 is being studied for efficacy and safety in adults with eosinophilic esophagitis in Phase…
-
CLINICAL_TRIALS other · 2026-03-19Clinical Trial Update: A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). [Phase 1, Phase 2]
Eupraxia Pharmaceuticals is recruiting adults with eosinophilic esophagitis for a Phase 1/2 trial of EP-104GI (NCT05608681).
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Eosinophilic Gastrointestinal Disorders Registry
A registry study for eosinophilic gastrointestinal disorders is currently recruiting. It is sponsored by Ann & Robert H Lurie Children's Hos…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
A pediatric clinical trial is evaluating whether low-dose topical steroids can maintain remission in eosinophilic esophagitis in children; t…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: EoE Food Test Pilot Study [NA]
A pilot clinical trial at Children's Hospital of Philadelphia is investigating a food-related test for eosinophilic esophagitis, with trial …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE [Phase 3]
A Phase 3 clinical trial is evaluating once-daily versus twice-daily budesonide orodispersible tablets for induction of remission in eosinop…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)
A clinical trial update on the ESCAPE study assessing the burden of esophageal cancer in eosinophilic esophagitis has completed.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany
Non-interventional observational study in Germany to evaluate the long-term efficacy and safety of dupilumab for eosinophilic esophagitis un…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Innate Immunity in Eosinophilic Esophagitis
A completed clinical trial investigating innate immunity in eosinophilic esophagitis, sponsored by Assistance Publique - Hôpitaux de Paris.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks [Phase 2]
This Phase 2 trial assesses vonoprazan 20 mg versus placebo in adults with eosinophilic esophagitis, evaluating outcomes after 12 weeks and …
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Study of CDX-0159 in Patients With Eosinophilic Esophagitis [Phase 2]
Clinical trial update indicating that the Phase 2 study of CDX-0159 in eosinophilic esophagitis has completed.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: The Immune Directed Individualized Elimination Therapy (iDIET) Study [NA]
This clinical trial update describes the iDIET study sponsored by the University of North Carolina at Chapel Hill, investigating treatment f…